Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
Login Archives Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
    ×
  • Subscribe
Enter stock ticker or keyword
×
Join 100,000+ Like-Minded Investors Today
Twitter
Tags: penny stocks
Stocks: CERU, MSDI, OPXA, OSUR, RTK

10 Penny Stock Gainers to Watch Closely in July 2017

By Alex McGuire, Associate Editor, Money Morning • @AlexMcGuire92 • July 6, 2017

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

The following list shows the top penny stock gainers of the first three sessions of July so far, which we'll be following closely throughout the month. We'll also show you one of the best small-cap stocks to buy in 2017 after the chart...

Penny Stock Current Price Month-to-Date Gain (as of July 6)
Monster Digital Inc. (Nasdaq: MSDI) $1.23 +152.1%
Cerulean Pharma Inc. (Nasdaq: CERU) $0.95 +112.9%
Rentech Inc. (Nasdaq: RTK) $0.66 +45.7%
Opexa Therapeutics Inc. (Nasdaq: OPXA) $0.88 +33.9%
Prana Biotechnology Ltd. (Nasdaq ADR: PRAN) $2.96 +29.3%
Centrais Eletricas Brasileiras SA (NYSE ADR: EBR) $4.65 +24.3%
DarioHealth Corp. (Nasdaq: DRIO) $2.63 +20.6%
North Atlantic Drilling Ltd. (NYSE: NADL) $1.60 +20.3%
Soleno Therapeutics Inc. (Nasdaq: SLNO) $0.61 +20.2%
BioLife Solutions Inc. (Nasdaq: BLFS) $2.85 +19.2%

The top penny stock of July has been Monster Digital, whose stock has surged 152.1% to $1.23 since Monday, July 3. Those gains came after Monster Digital and private firm Innovate Biopharmaceuticals announced a reverse merger...

A reverse merger lets a private company go public without raising funding for an IPO, which can be an expensive and laborious process. Because it's not raising capital through outside investors, the reverse merger process doesn't depend entirely on how much investors and traders are willing to pay for shares of the company. It's used solely to convert a private firm into a public firm by getting help from an already public firm.

For Monster Digital and Innovate's reverse merger, the new public company will retain the name of Innovate Biopharmaceuticals, with analysts saying Innovate's pre-existing business will be valued at $60 million and Monster's at $6 million. The deal also gives Innovate a new stock ticker, and private individuals already invested in Innovate will hold 90.9% of the combined company.

Since MSDI stock will be reduced to 9.1% of the newly merged firm, the short supply of MSDI shares has boosted buying interest. That's why shares have rocketed 152.1% in just three days.

BRILLIANT: Average Americans Are Becoming Marijuana Millionaires

Despite the double- and triple-digit returns reaped by MSDI and the other firms listed in the chart above, we don't advise buying them right now. Because they've seen those gains already, now might not be the best time to invest since they currently trade at higher prices.

Buying soaring penny stocks like these can be very risky for investors who haven't done any research. When searching for the best penny stocks to buy, digging into financial documents like 10-K filings and recent earnings reports is essential.

penny stock gainersThese reports will indicate if a firm is legitimate and if a firm's profitability is growing. If it doesn't meet those standards, it's likely not worth your money.

But Money Morning Small-Cap Specialist Sid Riggs prefers to conduct this arduous research for our readers. While many of his recommendations cost more than $5 per share, these companies boast bigger market caps, anywhere from $300 million to $2 billion. That shows they attract more investors because they're often more financially stable than regular penny stocks.

Today, Sid - whose recent pick has given Money Morning Members a 19.7% profit since he first recommended it on April 19 - just recommended another small-cap stock pick. It's a pharmaceutical company that has a strong track record of FDA approval for its products, including one that will be the first of its kind sold over the counter.

But the most impressive aspect of this firm is its astonishing earnings record. It has crushed earnings expectations by an average of 57.6% over the last four quarters.

According to Sid, that's a sign Wall Street underestimates how much this company could grow in 2017, making now the perfect time to buy shares.

Here's Sid's newest small-cap stock pick for double-digit growth in 2017...

One of the Best Small-Cap Stocks to Buy in 2017

Here Are 10 “One-Click” Ways to Earn 10% or Better on Your Money Every Quarter

Appreciation is great, but it’s possible to get even more out of the shares you own. A lot more: you can easily beat inflation and collect regular income to spare. There are no complicated trades to put on, no high-level options clearances necessary. In fact, you can do this with a couple of mouse clicks – passive income redefined. Click here for the report…

Claim My Free Report

Subscribe
Login
Notify of
guest

guest

0 Comments
Inline Feedbacks
View all comments


Latest News

September 15, 2023 • By Shah Gilani

We're Headed for a Second Banking Crisis - Here's What to Do

September 14, 2023 • By Tom Gentile

Tulips Are the Secret to Trading the Next 300% Rally in AI

September 14, 2023 • By Chris Johnson

Tulips Are Telling Me How To Trade the Next 300% rally in AI
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Penny Hawk Midday Momentum
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Quantum Data Profits Flashpoint Trader Darknet Alpha Accelerators Brutus Alerts Resource Traders Alliance L.A.U.N.C.H. Investor Rob Roy Trader Long-Term Equity Profits

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information

wpDiscuz